The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(2-Chloro-4-(3-methyl-2-oxopyridin-1(2H)-yl)phenyl)-8-(2-(3-fluoro-1-methylazetidin-3-yl)ethyl)-2-(methylamino)pyrido-[2,3-d]pyrimidin-7(8H)-one ID: ALA3818265
PubChem CID: 127048386
Max Phase: Preclinical
Molecular Formula: C26H26ClFN6O2
Molecular Weight: 508.99
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNc1ncc2cc(-c3ccc(-n4cccc(C)c4=O)cc3Cl)c(=O)n(CCC3(F)CN(C)C3)c2n1
Standard InChI: InChI=1S/C26H26ClFN6O2/c1-16-5-4-9-33(23(16)35)18-6-7-19(21(27)12-18)20-11-17-13-30-25(29-2)31-22(17)34(24(20)36)10-8-26(28)14-32(3)15-26/h4-7,9,11-13H,8,10,14-15H2,1-3H3,(H,29,30,31)
Standard InChI Key: KHDMDYBLHAGOQS-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
-3.9072 2.7019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 1.5019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 1.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 3.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6034 5.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6437 5.8457 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2347 4.8152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8492 6.2648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1889 6.8668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2988 6.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8926 -1.4990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8904 -2.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1883 -3.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4885 -3.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4907 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1928 -0.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1947 0.4490 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.7870 -3.7553 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0861 -3.0052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3852 -3.7551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3853 -5.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0863 -6.0052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0864 -7.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7872 -5.2553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7481 -5.8554 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
17 19 1 0
14 19 1 0
11 20 1 0
6 20 1 0
20 21 2 0
3 21 1 0
8 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
22 27 1 0
27 28 1 0
25 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
33 35 1 0
29 35 1 0
35 36 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.99Molecular Weight (Monoisotopic): 508.1790AlogP: 3.66#Rotatable Bonds: 6Polar Surface Area: 85.05Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.57CX LogP: 2.97CX LogD: 2.96Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: -1.16
References 1. Rudolph J, Murray LJ, Ndubaku CO, O'Brien T, Blackwood E, Wang W, Aliagas I, Gazzard L, Crawford JJ, Drobnick J, Lee W, Zhao X, Hoeflich KP, Favor DA, Dong P, Zhang H, Heise CE, Oh A, Ong CC, La H, Chakravarty P, Chan C, Jakubiak D, Epler J, Ramaswamy S, Vega R, Cain G, Diaz D, Zhong Y.. (2016) Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window., 59 (11): [PMID:27167326 ] [10.1021/acs.jmedchem.6b00638 ]